Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Incremental Dose Escalation Trial of Safety and Tolerability of Curcumin

NCT06626230 is registered in ClinicalTrials.gov with Lisa Flowers as lead sponsor.

NCT NCT06626230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06626230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Incremental Dose Escalation Trial of Safety and Tolerability of Curcumin
Lead sponsor
Lisa Flowers
Phase
Phase 1
Overall status
Recruiting
Start date
March 17, 2025
Completion date
December 31, 2026
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anal high grade squamous intraepithelial lesion